Recently, the AI orthopedic robot system independently developed by Beijing Changmugu Company has triggered a high level of attention from the global medical industry with a series of core innovations. The system empowers the whole process of orthopedic surgery with artificial intelligence technology, and has successfully achieved remarkable results in improving surgical precision, reducing medical costs and promoting the popularization of the technology.
With the intelligent image processing system, the system is based on the annotation training of 100,000 medical images (covering a data volume of 10 million), and realizes the efficient generation of complex surgical planning in 5 to 10 minutes, which traditionally takes several hours to complete. In addition, the 3D visualized surgical plan generated by the system can accurately present key data such as osteotomy parameters, providing doctors with intuitive and clear preoperative guidance. Through these innovations, the accuracy of surgery has been significantly improved, and clinical trials have shown that its AI 3D surgical simulation technology can increase the accuracy of orthopedic surgery to over 97%!
It is worth noting that the Changmugu AI orthopedic robotic system has also achieved significant milestones in terms of certification. in October 2023, the system was the first to be certified as a Class III Innovative Medical Device by China's National Medicines and Drug Administration (NMPA). This was followed in August 2024 by successful certification by the U.S. Food and Drug Administration (FDA). In 2025, the system will be certified by CE in EU and MOH in Southeast Asia, becoming the world's first AI orthopedic therapeutic Class III innovative medical device to be certified in four major markets: China, US, EU and Southeast Asia, which marks a major breakthrough of China's smart manufacturing in the field of high-end medical devices.
At present, Changmugu AI orthopedic robotic system has been successfully applied in more than 1,000 medical institutions across the country, widely covering the network of medical institutions at all levels. With the implementation of the national collection and procurement policy, the cost of hip replacement surgery has been reduced from 100,000 yuan to 20,000 to 30,000 yuan in the past, so that more patients can enjoy cost-effective advanced medical technology. Meanwhile, the average number of surgeries completed by a single device exceeds 1,000 per year, effectively easing the contradiction between the supply and demand of medical resources.